The Brazilian-Uruguayan startup PUCMED (Productora Uruguaya de Cannabis Medicinal) is preparing to be the first in the country to go public on the stock exchange. Headquartered in...
The prescription products will be commercialized in partnership with IPS Pharma, an established company with more than 20 years of experience with unlicensed medicines. TORONTO, Feb....
Canada’s Globe & Mail reports on their court case A years-long access-to-information battle between journalists and Health Canada over data on the locations of large-scale medical cannabis...
In the wilds of North Texas, a K-9 with a keen nose for trouble sniffed out a suspicious pair of travelers, who were hauling a trailer...
Good luck with that , we say! Avis de bon sens rendu par le Cese. En tant que maire confronté aux trafics, je propose à @EmmanuelMacron...
LOVE Hemp has responded to damning allegations made publicly by its former managing director Philip Small, who left the company in November 2022. The Aquis-listed CBD...
BusinessCann YESTERDAY morning Cellular Goods informed investors that its proposed £18.6m reverse-takeover deal with Cannaray has been scrapped. In a brief RNS, the CBD retailer said...
Dear Stakeholders, Welcome to the MED’s first e-Newsletter! We are excited to share this publication with you. We developed this e-newsletter to share recent happenings at the MED,...
FRANKFURT-based medical cannabis holding company Bloomwell Group (“Bloomwell,” “Bloomwell Group,” or the “Company”) has closed a significant multi-million Euro funding round led by Artemis Growth Partners (“Artemis”), a premier American...
This is good to see They Write Please Support SB 302, To Expand Ryan’s Law Protections to Seniors with Chronic Pain SB 302 would expand the...
